CN113929651A - Method for synthesizing alpha-pyrone compound - Google Patents

Method for synthesizing alpha-pyrone compound Download PDF

Info

Publication number
CN113929651A
CN113929651A CN202111343068.6A CN202111343068A CN113929651A CN 113929651 A CN113929651 A CN 113929651A CN 202111343068 A CN202111343068 A CN 202111343068A CN 113929651 A CN113929651 A CN 113929651A
Authority
CN
China
Prior art keywords
alpha
pyrone
synthesizing
cyclopropenone
bromoacetophenone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111343068.6A
Other languages
Chinese (zh)
Other versions
CN113929651B (en
Inventor
徐四龙
张科强
乔丽娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi'an Yutebang Pharmaceutical Technology Co ltd
Original Assignee
Xi'an Yutebang Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi'an Yutebang Pharmaceutical Technology Co ltd filed Critical Xi'an Yutebang Pharmaceutical Technology Co ltd
Priority to CN202111343068.6A priority Critical patent/CN113929651B/en
Publication of CN113929651A publication Critical patent/CN113929651A/en
Application granted granted Critical
Publication of CN113929651B publication Critical patent/CN113929651B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an alpha-pyrone compound and a synthesis method thereof, wherein DMAP is used for catalyzing bromoacetophenone and cyclopropenone to generate a [3+3] cyclization reaction under an alkaline heating condition to generate the alpha-pyrone compound. Because the alpha-pyrone drugs have wide clinical application, the invention provides a new method for synthesizing the alpha-pyrone compounds, and is expected to provide a new direction for the clinical application of the pyrone. The synthesis method disclosed by the invention is simple to operate, the raw materials are easy to obtain, the reaction conditions are mild, no metal catalyst is needed, the product is easy to separate and purify, the technical difficulties of complicated steps and complex raw materials of the synthesis method in the prior art are solved, the synthesis method is a breakthrough in the prior synthesis technology, and the synthesis method has high application value.

Description

Method for synthesizing alpha-pyrone compound
Technical Field
The invention belongs to the technical field of chemical synthesis, and particularly relates to a synthetic method of an alpha-pyrone compound.
Background
Pyrones are ketone derivatives of pyrans, which are widely found in nature, mainly in plants. Substances such as benzopyrans (chromenes), chromones, coumarins, flavones, isoflavones, anthocyanidins, and the like, are all considered to be derivatives of pyrones. Pyrone has two isomers which are alpha-pyrone and gamma-pyrone, wherein the alpha-pyrone is hexatomic ring unsaturated lactone, widely exists in a plurality of natural products, and has extremely wide application in the fields of medicines, pesticides, perfumes, dyes and the like, the alpha-pyrone also has good biological activity, and the alpha-pyrone is also an important intermediate in organic synthesis. The conjugated diene structure of the conjugated diene is easy to generate Diels-Alder reaction.
Due to the structural particularity of alpha-pyrone, the synthesis of alpha-pyrone has become a hot spot of research at home and abroad in recent years. The synthesis method of alpha-pyrone reported in the past has the limitations of long steps, complex raw materials, troublesome operation, high temperature condition, expensive metal catalyst and the like. Therefore, a new method for synthesizing the alpha-pyrone compound is developed, and the method becomes urgent.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide a synthetic method of an alpha-pyrone compound, which has simple operation, does not need a metal catalyst and has easily obtained raw materials.
In order to achieve the purpose, the invention adopts the following technical scheme to realize the purpose:
the invention discloses a synthesis method of an alpha-pyrone compound, which is characterized in that bromoacetophenone and cyclopropenone are subjected to [3+3] cyclization reaction under the catalysis of 4-dimethylaminopyridine under the alkaline heating condition to synthesize the alpha-pyrone compound, wherein:
the structural formula of bromoacetophenone is as follows:
Figure RE-GDA0003408519410000021
the structural formula of cyclopropenone is as follows:
Figure RE-GDA0003408519410000022
the structural formula of the synthesized alpha-pyrone compound is as follows:
Figure RE-GDA0003408519410000023
wherein R is1,R2,R3The group is alkyl or aryl.
Preferably, the method for synthesizing the alpha-pyrone compound comprises the following steps:
1) under the protection of nitrogen, adding bromoacetophenone and cyclopropenone into an alkaline organic solvent, stirring under the catalysis of 4-dimethylaminopyridine for 8-14 h under the heating condition, and cooling to room temperature after the reaction is finished;
2) and filtering, concentrating and purifying the reaction system by column chromatography to obtain the alpha-pyrone compound.
Further preferably, the reaction molar ratio of the cyclopropenone, the bromoacetophenone and the 4-dimethylaminopyridine is 1.0 (1.0-1.5) to 1.0-1.5.
More preferably, the reaction charge ratio of the cyclopropenone to the organic solvent is 0.2mmol (1-2) mL.
Further preferably, the organic solvent is 1, 4-dioxane, made basic by the addition of potassium hydroxide.
Further preferably, the heating temperature is 50 to 65 ℃.
Still more preferably, the heating temperature is 60 ℃.
Further preferably, in the step 1), the column chromatography adopts a silica gel chromatographic column, and the weight ratio of petroleum ether: ethyl acetate ═ 20:1 volume ratio through the column.
Compared with the prior art, the invention has the following beneficial effects:
the invention discloses a synthetic method of an alpha-pyrone compound, which is characterized in that bromoacetophenone and cyclopropenone are subjected to a [3+3] cyclization reaction under the catalysis of DMAP and the alkaline heating condition to efficiently synthesize the alpha-pyrone compound. In the synthetic method, the adopted reaction raw materials of cyclopropenone and bromoacetophenone are both convenient to obtain, and the problem of complex raw material source in the prior art is solved; the reaction product is subjected to a [3+3] cyclization reaction under an alkaline heating condition to obtain a target product, the reaction condition is consistent and does not need to be adjusted, and a metal catalyst does not need to be added in the reaction system, so that on one hand, impurities such as metal and the like cannot be introduced into the system, on the other hand, the separation and purification processes of the product are simple, and the synthesis method is simple in operation and mild in reaction condition.
Furthermore, in the synthesis method provided by the invention, the reaction is carried out at 60 ℃, so that the high conversion rate of the alpha-pyrone compound can be ensured, and the convenience and the safety of the operation can be ensured.
Drawings
FIG. 1 is a diagram showing a reaction mechanism for synthesizing an α -pyrone compound according to the present invention.
Detailed Description
In order to make the technical solutions of the present invention better understood, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
It is noted that the terms "comprises" and "comprising," and any variations thereof, in the description and claims of this invention, are intended to cover a non-exclusive inclusion, such that a process, method, system, article, or apparatus that comprises a list of steps or elements is not necessarily limited to those steps or elements expressly listed, but may include other steps or elements not expressly listed or inherent to such process, method, article, or apparatus.
The invention is described in further detail below with reference to the accompanying drawings:
the invention discloses a synthesis method of an alpha-pyrone compound, which is characterized in that bromoacetophenone and cyclopropenone are subjected to a [3+3] cyclization reaction under the condition of alkaline heating by DMAP catalysis to generate the alpha-pyrone compound.
The mechanism of the (3 + 3) cyclization reaction is that firstly bromoacetophenone and DMAP react to generate an intermediate A, then KOH pulls out hydrogen at a carbonyl alpha-position to generate a nitrogenous ylide B, the intermediate B and the intermediate C are subjected to tautomerization and attack on the side with smaller steric hindrance of cyclopropenone to generate an intermediate D, and the ketene structure E generated by DMAP leaving undergoes the (3 + 3) cyclization reaction to generate the final product alpha-pyrone. The reaction mechanism is shown in FIG. 1.
Bromoacetophenone and cyclopropenone are generated under the condition of alkaline heating, and the reaction formula is as follows:
Figure RE-GDA0003408519410000041
in the above reaction formula, R1,R2,R3The groups are alkyl and aryl;
the method comprises the following steps: under the protection of nitrogen, bromoacetophenone and cyclopropenone are added into an alkaline organic solvent, and DMAP is catalyzed and stirred for 12 hours under the heating condition; after the reaction is finished, cooling to room temperature; filtering, rotary steaming, concentrating, and performing column chromatography to obtain alpha-pyrone compounds;
preferably, the ratio of the cyclopropenone A to the bromoacetophenone B in the method of the invention is 1: 1.5; the solvent adopted in the invention is 1, 4-dioxane; the mol ratio of the cyclopropenone A to the 1, 4-dioxane is as follows: 0.2 mmol/1-2 mL; the temperature adopted by the heating of the invention is 60 ℃;
example 1
Diphenylcyclopropenone (0.2mmol), 2-bromo-1-4- (trifluoromethoxy) acetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol) were added to 100mg of 4A molecular sieve (for water removal, reaction was controlled under anhydrous conditions) and 1, 4-dioxane (2.0mL) under nitrogen, heated at 60 ℃ for 12h, after reaction was complete, cooled to room temperature, filtered, concentrated by vacuum distillation and purified by flash column chromatography (silica gel, mixture of petroleum ether/ethyl acetate, 20:1, v/v) to afford 67.3mg of the desired pure product in 82% yield as a yellow solid with melting point 134-136 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000042
1H NMR(400MHz,CDCl3)(δ,ppm):7.93(d,J=8.9Hz,2H,Ar-H),7.38–7.13 (m,13H,Ar-H),6.82(s,1H,Ar-H).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):162.4,156.7,152.5,150.7,137.5, 133.5,130.8,129.8,128.8,128.6,128.4,128.0,127.8,127.2,123.5,121.1,105.4.
IRνmax(neat):1697,1504,1266,1210,1150,833,,789,769,699cm-1.
HRMS(ESI)calcd for C24H15F3O3[M+H]+:409.1046,found:409.1048.
example 2
The procedure is as described in example 1, except that the substrates used are: diphenyl cyclopropenone (0.2mmol), 2-bromo-1-4- (trifluoromethyl) acetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) to obtain 59.5mg of product, yield of 76%, yellow solid of product, and melting point of 170-172 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000051
1H NMR(400MHz,CDCl3)(δ,ppm):8.03(d,J=8.2Hz,2H,Ar-H),7.74(d,J =8.3Hz,2H,Ar-H),7.32–7.15(m,10H,Ar-H),6.93(s,1H,Ar-H).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):162.2,156.3,152.2,137.3,134.5, 133.4,130.7,128.9,128.6,128.4,1278.0 128.0,126.0,125.9,125.7,124.3,106.3.
IRνmax(neat):1697,1537,1329,1160,1117,1072,831,789,699cm-1.
HRMS(ESI)calcd for C24H15F3O2[M+H]+:393.1097,found:393.1100
example 3
The procedure is as described in example 1, except that the substrates used are: diphenyl cyclopropenone (0.2mmol), 2-bromo-1-cyclohexylethanone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) are heated at 65 ℃ to obtain 27.8mg of a product, the yield is 42%, the product is a white solid, and the melting point is 124-125 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000052
1H NMR(400MHz,CDCl3)(δ,ppm):7.25–7.07(m,10H,Ar-H),6.13(s,1H, Ar-H),2.49(t,J=11.6Hz,1H,CH),2.07(d,J=13.2Hz,2H,CH2),1.86(d,J=12.9 Hz,2H,CH2),1.75(d,J=15.2Hz,1H,CH2),1.57–1.18(m,5H,CH2).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):167.89,163.63,152.84,137.97, 134.10,130.93,128.77,128.64,128.32,128.02,127.57,122.18,104.50,42.32,30.65, 25.87.
IRνmax(neat):2929,2853,1699,1634,1538,944,764,606,564cm-1.
HRMS(ESI)calcd for C23H22O2[M+H]+:331.1693,found:331.1690.
example 4
The procedure is as described in example 1, except that the substrates used are: 2-butyl-3-phenyl cyclopropenone (0.2mmol), bromoacetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) are heated at 55 ℃ to obtain 26.8mg of a product, the yield is 44%, the product is a yellow solid, and the melting point is 92-94 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000061
1H NMR(400MHz,CDCl3)(δ,ppm):7.90–7.86(m,2H,Ar-H),7.49–7.41 (m,5H,Ar-H),7.38(m,1H,Ar-H),7.31–7.28(m,2H,Ar-H),6.67(m=s,1H,Ar-H), 2.39(m 2H,CH2),1.51-1.55(m,2H,CH2),1.31–1.24(m,2H,CH2),0.83(t,J=7.3 Hz,3H,CH3).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):162.65,158.22,155.66,134.13, 131.60,130.61,130.02,128.96,128.48,128.05,125.61,124.33,103.89,33.11,31.41, 22.53,13.80.
IRνmax(neat):2962,2927,1706,1627,1538,1451,1351,722,692cm-1.
HRMS(ESI)calcd for C21H20O2[M+H]+:305.1536,found:305.1537
example 5
The procedure is as described in example 1, except that the substrates used are: bis- (4-methylphenyl) cyclopropenone (0.2mmol), bromoacetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), heating at 50 ℃ and 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) to obtain 26.2mg of a product, wherein the yield is 50%, the product is a yellow solid, and the melting point is 174-176 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000071
1H NMR(400MHz,CDCl3)(δ,ppm):7.88(d,J=9.7Hz,2H,Ar-H),7.63(d, J=8.2Hz,2H,Ar-H),7.56(d,J=7.2Hz,1H,Ar-H),7.47(d,J=7.1Hz,3H,Ar-H), 7.25(d,J=9.4Hz,2H,Ar-H),6.78(d,J=7.2Hz,1H,Ar-H),2.39(s,3H,CH3).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):161.61,159.57,139.75,138.61, 131.95,131.35,130.71,129.25,129.02,128.08,125.81,125.53,101.85,21.36.
IRνmax(neat):1711,1622,1556,1495,1115,902,823,762,685cm-1.
HRMS(ESI)calcd for C18H14O2[M+H]+:263.1067,found:263.1066.
example 6
The procedure is as described in example 1, except that the substrates used are: 2-3-bis (4-methylphenyl) cyclopropenone (0.2mmol), bromoacetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) to obtain a product 42.2mg, wherein the yield is 59%, the product is a yellow solid, and the melting point is 158-160 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000072
1H NMR(400MHz,CDCl3)(δ,ppm):7.90(m,2H,Ar-H),7.51–7.44(m,3H, Ar-H),7.08(d,J=6.6Hz,8H,Ar-H),6.82(s,1H,Ar-H),2.32(d,J=6.2Hz,6H, CH3).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):163.05,157.94,152.35,138.84, 137.46,135.07,131.60,131.07,130.77,130.67,129.17,128.99,128.86,128.75, 125.63,122.94,105.21,21.41.
IRνmax(neat):1701,1625,1531,1350,979,815,726,690,646cm-1.
HRMS(ESI)calcd for C25H20O2[M+H]+:353.1536,found:353.1536.
example 7
The procedure is as described in example 1, except that the substrates used are: 2-3-bis (4-fluorophenyl) cyclopropenone (0.2mmol), bromoacetophenone (0.3mmol), DMAP (20 mol%), KOH (0.3mmol), 100mg of 4A molecular sieve and 1, 4-dioxane (2.0mL) to obtain 64.1mg of a product, wherein the yield is 89%, the product is a yellow solid, and the melting point is 204-206 ℃. The structural formula is as follows:
Figure RE-GDA0003408519410000081
1H NMR(400MHz,CDCl3)(δ,ppm):7.93–7.88(m,2H,Ar-H),7.51–7.46 (m,3H,Ar-H),7.20–7.12(m,4H,Ar-H),7.01–6.92(m,4H,Ar-H),6.80(s,1H,Ar- H).
13C{1H}NMR(400MHz,CDCl3;δ,ppm):164.09,164.05,163.51,162.61, 161.60,161.04,158.66,151.96,133.67,133.63,132.80,132.72,131.23,131.06, 130.78,130.69,129.62,129.58,129.11,125.72,122.16,115.93,115.72,115.46, 115.24,104.76.
IRνmax(neat):1687,1536,1351,1223,1157,842,762,557,543cm-1.
HRMS(ESI)calcd for C23H14F2O2[M+H]+:361.1035,found:361.1037.
the above-mentioned contents are only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited thereby, and any modification made on the basis of the technical idea of the present invention falls within the protection scope of the claims of the present invention.

Claims (8)

1. A synthetic method of an alpha-pyrone compound is characterized in that the alpha-pyrone compound is synthesized by catalyzing bromoacetophenone and cyclopropenone to generate a [3+3] cyclization reaction under the condition of alkaline heating by 4-dimethylaminopyridine, wherein:
the structural formula of bromoacetophenone is as follows:
Figure FDA0003352770970000011
the structural formula of cyclopropenone is as follows:
Figure FDA0003352770970000012
the structural formula of the synthesized alpha-pyrone compound is as follows:
Figure FDA0003352770970000013
wherein R is1,R2,R3The group is alkyl or aryl.
2. The method for synthesizing α -pyrone compounds according to claim 1, comprising the steps of:
1) under the protection of nitrogen, adding bromoacetophenone and cyclopropenone into an alkaline organic solvent, stirring under the catalysis of 4-dimethylaminopyridine for 8-14 h under the heating condition, and cooling to room temperature after the reaction is finished;
2) and filtering, concentrating and purifying the reaction system by column chromatography to obtain the alpha-pyrone compound.
3. The method for synthesizing the alpha-pyrones according to claim 2, wherein the reaction molar ratio of the cyclopropenone, the bromoacetophenone and the 4-dimethylaminopyridine is 1.0 (1.0-1.5) to 1.0-1.5.
4. The method for synthesizing the alpha-pyrone compound according to claim 2, wherein the reaction charge ratio of the cyclopropenone to the organic solvent is 0.2mmol (1-2) mL.
5. The method for synthesizing α -pyrones according to claim 2, wherein the organic solvent is 1, 4-dioxane and is adjusted to be basic by adding potassium hydroxide.
6. The method for synthesizing the α -pyrone compound according to claim 2, wherein the heating temperature is 50 to 65 ℃.
7. The method for synthesizing α -pyrone compounds according to claim 6, wherein the heating temperature is 60 ℃.
8. The method for synthesizing α -pyrone compounds according to claim 2, wherein in step 1), the column chromatography is performed using a silica gel column, and the ratio of petroleum ether: ethyl acetate ═ 20:1 volume ratio through the column.
CN202111343068.6A 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound Active CN113929651B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111343068.6A CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111343068.6A CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Publications (2)

Publication Number Publication Date
CN113929651A true CN113929651A (en) 2022-01-14
CN113929651B CN113929651B (en) 2023-07-07

Family

ID=79286661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111343068.6A Active CN113929651B (en) 2021-11-12 2021-11-12 Method for synthesizing alpha-pyrone compound

Country Status (1)

Country Link
CN (1) CN113929651B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116354914A (en) * 2023-04-10 2023-06-30 河南科技大学 Triphenylsubstituted pyrone derivative and synthetic method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007305616A (en) * 2006-05-08 2007-11-22 Osaka Univ Novel organic element
CN113150006A (en) * 2021-02-02 2021-07-23 五邑大学 Pyran compound and synthetic method thereof
CN113214204A (en) * 2021-05-13 2021-08-06 河南师范大学 Synthesis method of 2-pyrone compound and alpha, beta-unsaturated chain ester compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007305616A (en) * 2006-05-08 2007-11-22 Osaka Univ Novel organic element
CN113150006A (en) * 2021-02-02 2021-07-23 五邑大学 Pyran compound and synthetic method thereof
CN113214204A (en) * 2021-05-13 2021-08-06 河南师范大学 Synthesis method of 2-pyrone compound and alpha, beta-unsaturated chain ester compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
RAO, P. N. PRAVEEN,ET AL: "6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
RAO, P. N. PRAVEEN,ET AL: "6-Alkyl, alkoxy, or alkylthio-substituted 3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 13, no. 13, 31 December 2003 (2003-12-31), pages 2205 - 2209 *
TIAN, HAIBIN,ET AL: "Synthesis of 18F-labeled cyclooxygenase-2 (COX-2) inhibitor as a potential PET imaging agent", 《JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS》 *
TIAN, HAIBIN,ET AL: "Synthesis of 18F-labeled cyclooxygenase-2 (COX-2) inhibitor as a potential PET imaging agent", 《JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS》, vol. 49, no. 7, 31 December 2006 (2006-12-31), pages 583 - 593, XP002487436, DOI: 10.1002/jlcr.1074 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116354914A (en) * 2023-04-10 2023-06-30 河南科技大学 Triphenylsubstituted pyrone derivative and synthetic method and application thereof

Also Published As

Publication number Publication date
CN113929651B (en) 2023-07-07

Similar Documents

Publication Publication Date Title
CN112608296B (en) Synthesis method of Brazilane natural product Brazilane
CN114380675B (en) Method for synthesizing aryl phenol by reacting halogenated aromatic hydrocarbon and phenol compound under induction of visible light
CN113929651B (en) Method for synthesizing alpha-pyrone compound
CN113861137B (en) Method for synthesizing furan compound by one-step reaction of ketone and alpha chloroketone
CN114920640A (en) Chlorocyclopentanone derivative and synthesis method thereof
CN114591277A (en) 5/6/7/6 tetracyclic compound fused with benzene ring and synthesis method thereof
CN107056795A (en) A kind of loop coil hydroxyindole pentamethylene and β lactones compound synthesis methods
CN107032972B (en) Preparation method of Diels-Alder product with 2' -hydroxychalcone structure
CN106946823B (en) Method for asymmetric synthesis of (R) -natural jasminolide
CN108467376A (en) A kind of synthetic method of dibenzofuran derivative
CN111454230A (en) Synthesis method of key intermediate Tuv of natural anticancer drug Tubulysins
CN111116530A (en) Method for synthesizing beraprost
CN113717132B (en) Key intermediate of antiepileptic drug and preparation method thereof
CN115991697A (en) Method for preparing cycloheptatriene epsilon-caprolactone compound
CN106316813B (en) 3-substituted 3-vinyl-2-hydroxy-1-aryl acetone and synthesis method thereof
CN111995605B (en) Chrysin cinnamate or its derivative and its preparation method
Bonacorso et al. Efficient entry to trifluoromethyl substituted chromanes from oxidative aromatization of tetrahydro-2H-chromen-5 (6H)-ones using iodine/alcohol with conventional and microwave methods
CN109384753B (en) Synthetic method of 2-phenyl-3-methylbenzofuran compound
CN114853707B (en) Method for synthesizing difluoro hydrogen methylation 2, 3-dihydro benzopyran-4-ketone derivative
CN112142709B (en) Synthetic method of 6-aryl-2,3,4,5-tetrahydrooxaheptin-3-alcohol derivative
CN116023357B (en) Method for converting o-hydroxyacetophenone into quaternary carbon center-containing chromanone compound
CN113292630B (en) Method for asymmetrically synthesizing Triptonide and Triptolide
CN115850216B (en) Stable isotope labeled 2, 5-furandicarboxylic acid-2-13Method for synthesizing COOH
CN111662318B (en) Iloprost key intermediate and preparation method thereof
CN113264972B (en) Method for preparing obeticholic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant